<!DOCTYPE html>

<html> 

<head> <!-- /main page header -->
  <meta charset="UTF-8">
   <meta name="format-detection" >
   <meta name="viewport" content="user-scalable=no, initial-scale=5, minimum-scale=1, maximum-scale=5">
   <title>BD-MIMS</title>
   <link rel="stylesheet" href="css/main.css">
   <link rel="stylesheet" href="css/themes/default/jquery.mobile-1.3.1.min.css">
   <script src="js/jquery.js"></script>
   <script src="js/jqm.js"></script>
   <script scr="js/cordova.js"type="text/javascript"></script>
   <script>
    function init() {
      document.addEventListener("deviceready", onDeviceReady, false);
    }

    function onDeviceReady() {
      alert('Damn Niagga, its playtime!');
    }
  </script>
   
</head> <!-- /main page header -->


<body onload="init()"> 


<div data-role="page" id="Contraceptive" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>Contraceptive Methods </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<a href="#" data-role="button" data-theme="a"> 
Oral contraceptive prepns. </a>
      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>COMBINED ORAL PILLS   </h3>
          <p> OESTROGEN + PROGESTERONE PREPN: Tablet (Pill).<br><br>
          Oestrogen and Progesterone preparations. Ind: Contraception; (control menopausal and menstrual symptoms- see in the early section under female sex hormones).<br><br>

          <strong>C/I:</strong> Pregnancy. History or presence of thrombophlebitis, thromboembolic
          disorders, cerebrovascular or cardiovascular diseases, sickle cell anaemia. Acute or ch. liver diseases, impaired hepatic excretory function; history of idiopathic jaundice of pregnancy. Herpes of pregnancy. Hormone-dependent carcinoma. Persistence of HCG levels after removal of hydatidiform mole. Abnormal vaginal bleeding.<br><br>

          <strong>S/E:</strong> Nausea, vomiting, headache, breast tenderness, changes in body weight. changes in libido, depression, chloasma, hypertension, impairment of liver function, benign hepatic tumours, reduced menstrual loss, spotting in early cycles, amenorrhoea; vaginal infection (e.g candidiasis).<br><br>

          <strong>Cautions:</strong> Diabetes, hypertension, cardiac or renal disease, migraine, epilepsy, depression, asthma, multiple sclerosis, wearing of contact lenses, uterine fibromyomata, lactation.
          Risk of arterial thrombosis associated with oral contraception is increased with age and aggravated by smoking and obesity.
          Examine blood pressure, pelvic organ and breasts before and regularly during treatment.<br><br>

          <strong>Dose:</strong> See under individual preparation.   </p>
        </div><!-- collapsible -->
        
        <div data-role="collapsible"> <!-- collapsible -->
            <h3>CILEST Tab. Cilag Ag/ Tajarat</h3>
            <p>CILEST Tab. Cilag Ag/ Tajarat 0.035mg: tablet</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>LYNDIOL Tab. Nuvista</h3>
            <p>Lynestrenol 2.5mg & Ethinyloestradiol 0.05mg: tablet.</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>MARVELON Tab. Nuvista</h3>
            <p>Ethinylestradiol 0.03mg & Desogestrel
        (a progestagen) 0.15mg/tablet.</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OVOSTAT Tab. Nuvista</h3>
            <p>Lynestrenol 1mg & ethinyloestradiol 0.05mg/tablet Ind; C/I; S/E; Cautions: See note at the beginning</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>OVOSTAT Gold Tab. Nuvista</h3>
            <p>Lynestrenol 1mg & Ethinyloestradiol 0.05mg ? /tablet.</p>   
        </div><!-- collapsible -->

      </div><!-- collapsible-set -->


<a href="#" data-role="button" data-theme="a"> 
Emergency Contraceptive Pill </a>
      <div data-role="collapsible-set" data-theme="b">
        <div data-role="collapsible"> <!-- collapsible -->
          <h3>LEVONORGESTREL</h3>
          <p> LEVONORGESTREL: Tablet<br><br>
Levonorgestrel is a synthetic progestogen
hormone. It is used as an 'emergency contraceptive pill'.<br><br>
<strong>Mode of action:</strong> Levonorgestrel is a progestogen. A single dose of 0.75mg levonorgestrel taken immediately after the sexual intercourse prevents conception. It acts by preventing or delaying ovulation, inhibiting fertilization or enhancing implantation depending on which part of the female cycle it is used.<br><br>
<strong>ind:</strong> Emergency oral contraception, to prevent unwanted pregnancy after unprotected intercourse (such as, usual intercourse without taking any contraceptive measure, broken condom, dislodged diaphragm, IUD loss or removal, unsuccessful withdrawal). Failure rate is only 2% in women who use it correctly. No more than 4 tablets can be taken monthly at 2-4 occasions. To females having sexual intercourses more frequently combined oral contraceptives (or other contraceptive methods) are recommended. Lactating mother can use it.<br><br>
<strong>C/I:</strong> Confirmed pregnancy. In case of vaginal bleeding of unknown origin, hepatic and biliary disease, history of gestational jaundice, breast, ovarian or uterine carcinoma, it should be administered after careful consideration of the risk/benefit ratio (unwanted pregnancy/aboriton).<br><br>
<strong>S/E:</strong> Nausea, break-through or withdrawal bleeding may occur 2-3 days after taking the tablets which may be reduced by Rutascorbin administration.
In case of more severe bleeding gynaecological examination is recommended before taking levonorgestrel again.<br><br>
<strong>Caution:</strong> Consult a gynecologist if necessary.<br><br>
<strong>Dosage & admin:</strong> 1 tablet within 72 hours after the event of unprotected intercourse and a second one 12 hours after the first. Do not delay treatment unnecessarily. As the use of this drug is ineffective & contraindicated in confirmed pregnancy, but its use does not interrupt an established pregnancy, and remains thereof without effect in these cases.
No more than 4 tablets are allowed to be taken per month.
 </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>EMCON Tab. Renata</h3>
            <p>Levonorgestrel 0.75mg/tablet. 2 tabs pack: 45.00 MRP</p>   
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
            <h3>POSTINOR-2 Tab. Gedeon Richter/City Overseas</h3>
            <p>Levonorgestrel 0.75mg/tablet.
        2 tabs pack: 25.00 TP</p>   
        </div><!-- collapsible -->

      </div><!-- collapsible-set -->

              
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->





	
</body> 
</html> 
